Loading... Please wait... Loading... Please wait...
ESTIMATED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | $2.79 | $2.79 | $2.79 |
| Q2 2024 | 0 | $2.14 | $2.14 | $2.14 |
| Q3 2024 | 0 | $1.84 | $1.84 | $1.84 |
| Q4 2024 | 0 | $2.11 | $2.11 | $2.11 |
Clearmind Medicine Inc. last posted its earnings results on N/A. The company reported $N/A earnings per share for the quarter, missing analysts' consensus estimates of $N/A by $0. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Clearmind Medicine Inc. has generated $-57 earnings per share over the last year ($-57.42 diluted earnings per share) and currently has a price-to-earnings ratio of -0.71. Clearmind Medicine Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, April 30th, 2023 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 06/13/2024 | Q2 2024 | -$0.28 | $0 | $0 | 03/18/2024 | Q1 2024 | -$0.90 | $0 | $0 | 01/29/2024 | Q4 2023 | -$11.44 | $0 | $0 | 09/13/2023 | Q3 2023 | -$2.43 | $0 | 06/14/2023 | Q2 2023 | -$16.62 | $0 | 03/17/2023 | Q1 2023 | -$32.11 | $0 | 02/03/2023 | Q4 2022 | -$59.65 | $0 | 07/31/2022 | Q3 2022 | -$49.77 | $0 | 04/30/2022 | Q2 2022 | -$79.32 | $0 | 01/31/2022 | Q1 2022 | -$51.00 | $0 | 10/31/2021 | Q4 2021 | -$60.22 | $0 | 07/31/2021 | Q3 2021 | -$30.93 | $0 | 04/30/2021 | Q2 2021 | -$8.99 | $0 | 01/31/2021 | Q1 2021 | -$4.70 | $0 | 10/31/2020 | Q4 2020 | -$2.68 | $0 | 07/31/2020 | Q3 2020 | -$5.10 | $0 | 04/30/2020 | Q2 2020 | -$3.63 | $0 | 01/31/2020 | Q1 2020 | -$2.08 | $0 | 10/31/2019 | Q4 2019 | -$2.08 | $0 | 07/31/2019 | Q3 2019 | -$1.81 | $0 |
|---|
A. Clearmind Medicine Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, April 30th, 2023 based off last year's report dates.
A. The conference call for Clearmind Medicine Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for Clearmind Medicine Inc.'s latest earnings report can be read online.
A. Clearmind Medicine Inc. (NASDAQ:CMND) has a recorded net income of $0. Clearmind Medicine Inc. has generated $-57.42 earnings per share over the last four quarters.
A. Clearmind Medicine Inc. (NASDAQ:CMND) has a price-to-earnings ratio of -0.71 and price/earnings-to-growth ratio is -0.01.
